 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
|
|
|
|
No phase specified
|
|
|
|
MSKCC-06113
NCT00398073
|
|
| |
Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
|
|
|
|
No phase specified
|
|
|
|
PCI-04173
04-173, PCI-IRB-0607048, 7357, NCT00471471
|
|
| |
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
|
|
|
|
No phase specified
|
|
|
|
JHOC-J0685
NA_00003073, J0685, NCT00499733
|
|
| |
Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye
|
|
|
|
No phase specified
|
|
|
|
IRB #25660007
NCT00621439
|
|
| |
Vaccine Therapy in Treating Patients With Advanced Melanoma
|
|
|
|
No phase specified
|
|
|
|
UVACC-MEL-48
Mel 48, UVACC-IRB-13498, UVACC-PRC-450-07, NCT00705640
|
|
| |
Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
|
|
|
|
Phase I
|
|
|
|
06C.46
NCT00405405
|
|
| |
A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients
|
|
|
|
Phase I
|
|
|
|
M06-862
NCT00526617
|
|
| |
Safety and Efficacy of Combination HDI and Anti-CTLA4 for Recurrent Inoperable Stage III or Stage IV Melanoma
|
|
|
|
Phase I
|
|
|
|
05-125
NCT00610857
|
|
| |
Phase 1 Open Label Study of MDX-1105 in Subjects With Solid Tumors
|
|
|
|
Phase I
|
|
|
|
MDX 1105-01
NCT00729664
|
|
| |
Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma
|
|
|
|
Phase II
|
|
|
|
MCC-15241
MDX-010-16, NCI-6446, 6446, NCT00084656, LAC-USC-10M036
|
|
